(Q43412741)

23 November 2017

title

Adenovirus delivery provides extended interferon-alpha exposure and augments treatment of metastatic carcinoma (English)

1 reference

23 November 2017

1 reference

E Brin

1

1 reference

23 November 2017

I Atencio

2

1 reference

23 November 2017

B K Helmich

3

1 reference

23 November 2017

D Maneval

4

1 reference

23 November 2017

D Laface

5

1 reference

23 November 2017

publication date

3 March 2006

1 reference

23 November 2017

1 reference

23 November 2017

volume

13

1 reference

23 November 2017

issue

7

1 reference

23 November 2017

page(s)

664-675

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700942

23 November 2017

exact match

0 references

cites work

The human interferon alpha species and receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Role of alpha interferon in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

IFNalpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Characterization of the antitumor activities of IFN-alpha8 on renal cell carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Retroviral IFN-alpha gene transfer combined with gemcitabine acts synergistically via cell cycle alteration in human pancreatic carcinoma cells implanted orthotopically in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Interferon-alpha suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Interferon-alpha: regulatory effects on cell cycle and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Clinical Pharmacokinetics of Interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Adenovirus-mediated in vivo gene transfer and expression in normal rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Assessment of recombinant adenoviral vectors for hepatic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

CD4+ T helper cell-independent antitumor response mediated by murine IFN-beta gene delivery in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Interferon-beta gene therapy improves survival in an immunocompetent mouse model of carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Undermining tumor angiogenesis by gene therapy: an emerging field

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

In vivo tumor suppression by adenovirus-mediated interferon alpha2b gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Immunological effects of interferon-alpha on chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Role of NK cells in tumour growth and metastasis in beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Interferon-alpha2b secretion by adenovirus-mediated gene delivery in rat, rabbit, and chimpanzee results in similar pharmacokinetic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Tumor growth inhibition by interferon-alpha using PEGylated protein or adenovirus gene transfer with constitutive or regulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

inferred from DOI database lookup

7 January 2021

based on heuristic

Pharmacokinetics of interferon alpha-2b in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700942

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700942

1 reference

Dimensions Publication ID

23 November 2017

1002888994

0 references

1 reference